Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov;13(11):674-686.
doi: 10.1038/nrendo.2017.99. Epub 2017 Sep 8.

Adult-onset Autoimmune Diabetes: Current Knowledge and Implications for Management


Adult-onset Autoimmune Diabetes: Current Knowledge and Implications for Management

Raffaella Buzzetti et al. Nat Rev Endocrinol. .


Adult-onset autoimmune diabetes is a heterogeneous disease that is characterized by a reduced genetic load, a less intensive autoimmune process and a mild metabolic decompensation at onset compared with young-onset type 1 diabetes mellitus (T1DM). The majority of patients with adult-onset autoimmune diabetes do not require insulin treatment for at least 6 months after diagnosis. Such patients are defined as having latent autoimmune diabetes in adults (LADA), which is distinct from classic adult-onset T1DM. The extensive heterogeneity of adult-onset autoimmune diabetes is apparent beyond the distinction between classic adult-onset T1DM and LADA. LADA is characterized by genetic, phenotypic and humoral heterogeneity, encompassing different degrees of insulin resistance and autoimmunity; this heterogeneity is probably a result of different pathological mechanisms, which have implications for treatment. The existence of heterogeneous phenotypes in LADA makes it difficult to establish an a priori treatment algorithm, and therefore, a personalized medicine approach is required. In this Review, we discuss the current understanding and gaps in knowledge regarding the pathophysiology and clinical features of adult-onset autoimmune diabetes and highlight the similarities and differences with classic T1DM and type 2 diabetes mellitus.

Similar articles

See all similar articles

Cited by 29 articles

See all "Cited by" articles


    1. Diabetologia. 2016 Jan;59(1):13-20 - PubMed
    1. J Clin Endocrinol Metab. 2000 Jan;85(1):76-80 - PubMed
    1. Diabetes. 2004 Dec;53(12):3193-200 - PubMed
    1. Diabetes Res Clin Pract. 1994 Jul;24(3):195-8 - PubMed
    1. Diabetes Metab Res Rev. 2005 Mar-Apr;21(2):203-8 - PubMed

MeSH terms